Cas no 73-31-4 (Melatonin)
Melatonin Chemical and Physical Properties
Names and Identifiers
-
- N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide
- 3-(N-ACETYL-2-AMINOETHYL)-5-METHOXYINDOLE
- 5-METHOXY-N-ACETYLTRYPTAMINE
- ACETYL-5-METHOXYTRYPTAMINE
- AKOS BB-4935
- MELATONIN
- MLT
- N-[2-(5-METHOXY-1H-INDOL-3-YL)ETHYL]ACETAMIDE
- N-(2-(5-methoxyindol-3-yl)ethyl)acetamide
- N-ACETYL-5-METHOXYTRYPTAMINE
- TIMTEC-BB SBB003265
- Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-
- Acetamide, N-[2-(5-methoxyindol-3-yl)ethyl]-
- Acetamide,N-[2-(5-methoxy-1H-indol-3-yl)ethyl]
- Melatonin(N-Acetyl-5-methoxytryptamine)
- n-(2-(5-methoxy-1h-indol-3-yl)ethyl)-acetamid
- n-(2-(5-methoxyindol-3-yl)ethyl)-acetamid
- 3-N-Acetyl-5-methoxyl tryptamine
- MELATONIN F&
- D VERSION FOR VETERINARY US
- Melatonin (MLT)
- MELATONIN(SH)
- Melatonine
- Circadin
- Melatonin (AS)
- Melovine
- primex
- [ "" ]
- Melatol
- Melatonex
- N-[2-(5-methoxyindol-3-yl)ethyl]acetamide
- N-acetyl-5-methoxy-tryptamine
- JL5DK93RCL
- Acetamide, N-(2-(5-methoxyindol-3-yl)ethyl)-
- BR
- MLS000859594
- MLS001240204
- MLS001055382
- SMR000326666
- MLSMR
- Melatonin standard substance
- Melatonin
-
- MDL: MFCD00005655
- Inchi: 1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)
- InChI Key: DRLFMBDRBRZALE-UHFFFAOYSA-N
- SMILES: COC1C=C2C(NC=C2CCNC(=O)C)=CC=1
Computed Properties
- Exact Mass: 232.12100
- Monoisotopic Mass: 232.121177757 g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 17
- Rotatable Bond Count: 4
- Complexity: 270
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: 2
- Molecular Weight: 232.28
- XLogP3: 0.8
- Topological Polar Surface Area: 54.1
Experimental Properties
- Color/Form: Powder
- Density: 1.1099 (rough estimate)
- Melting Point: 116.5-118?°C (lit.)
- Boiling Point: 512.8°C at 760 mmHg
- Flash Point: Degrees Fahrenheit:48.2°F
Degrees Celsius:9°C - Refractive Index: 1.6450 (estimate)
- Solubility: Soluble in ethanol to at least 50mg/ml
- PSA: 54.12000
- LogP: 2.24600
- Merck: 5816
- Color/Form: 1.0?mg/mL in methanol
- Solubility: Uncertain
- Sensitiveness: Sensitive to light
- Vapor Pressure: 1.4X10-7 mm Hg at 25 °C (est)
Melatonin Security Information
-
Symbol:
- Signal Word:Danger
- Hazard Statement: H225-H301 + H311 + H331-H370
- Warning Statement: P210-P260-P280-P301+P310-P311
- Hazardous Material transportation number:NONH for all modes of transport
- WGK Germany:2
- Hazard Category Code: 11-23/24/25-39/23/24/25
- Safety Instruction: S24/25
- FLUKA BRAND F CODES:8-10-23
- Regulatory Condition Code:Class Q (sugars, alkaloids, antibiotics, hormones)
- RTECS:AC5955000
-
Hazardous Material Identification:
- Storage Condition:Powder -20°C 3 years ? 4°C 2 years In solvent -80°C 6 months ? -20°C 1 month
- Risk Phrases:R60
Melatonin Customs Data
- HS CODE:2932999099
- Customs Data:
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Melatonin Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| MedChemExpress | HY-B0075-10mM*1mLinDMSO |
Melatonin |
73-31-4 | 99.73% | 10mM*1mLinDMSO |
¥500 | 2023-07-26 | |
| MedChemExpress | HY-B0075-500mg |
Melatonin |
73-31-4 | 99.93% | 500mg |
¥350 | 2025-04-16 | |
| MedChemExpress | HY-B0075-1g |
Melatonin |
73-31-4 | 99.93% | 1g |
¥500 | 2025-04-16 | |
| MedChemExpress | HY-B0075-5g |
Melatonin |
73-31-4 | 99.93% | 5g |
¥1050 | 2025-04-16 | |
| ChemFaces | CFN90037-20mg |
Melatonin |
73-31-4 | >=98% | 20mg |
$40 | 2021-07-22 | |
| HE FEI BO MEI SHENG WU KE JI YOU XIAN ZE REN GONG SI | TM0711-100g |
Melatonin |
73-31-4 | ≥99% | 100g |
¥950元 | 2023-09-15 | |
| HE FEI BO MEI SHENG WU KE JI YOU XIAN ZE REN GONG SI | TM0711-25g |
Melatonin |
73-31-4 | ≥99% | 25g |
¥320元 | 2023-09-15 | |
| HE FEI BO MEI SHENG WU KE JI YOU XIAN ZE REN GONG SI | TM0711-5g |
Melatonin |
73-31-4 | ≥99% | 5g |
¥80元 | 2023-09-15 | |
| DC Chemicals | DCT-015-20 mg |
Melatonine |
73-31-4 | 20mg |
$280.0 | 2022-02-28 | ||
| S e l l e c k ZHONG GUO | S1204-10mM (1mL in DMSO) |
Melatonin (NSC 113928) |
73-31-4 | 99.95% | 10mM (1mL in DMSO) |
¥732.95 | 2023-09-16 |
Melatonin Suppliers
Melatonin Related Literature
-
Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
-
Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
-
Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
-
Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
-
Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
Additional information on Melatonin
Melatonin (73-31-4): Chemical Structure and Biological Significance
Melatonin, with the CAS number 73-31-4, is a naturally occurring hormone primarily synthesized by the pineal gland. Its chemical structure, N-acetyl-5-methoxytryptamine, plays a pivotal role in regulating circadian rhythms and sleep-wake cycles. Recent studies highlight its antioxidant properties, which combat oxidative stress and inflammation, making it a focal point in aging and neurodegenerative disease research. The molecular mechanism involves binding to MT1 and MT2 receptors, influencing physiological processes like immune modulation and metabolic regulation. As a low-molecular-weight compound (232.28 g/mol), melatonin's lipophilic nature allows it to cross the blood-brain barrier efficiently, enhancing its therapeutic potential for insomnia and jet lag. Researchers are also exploring its synergy with other neuroprotective agents, underscoring its versatility in biomedical applications.
Melatonin (73-31-4): Pharmacological Effects and Clinical Applications
The pharmacological profile of melatonin (73-31-4) extends beyond sleep regulation. Clinical trials demonstrate its efficacy in managing seasonal affective disorder (SAD) and shift work sleep disorder, with doses ranging from 0.5 mg to 10 mg. Its anti-inflammatory and immunomodulatory effects are being investigated for COVID-19 adjuvant therapy, as it may mitigate cytokine storms. Notably, melatonin's oncostatic properties have sparked interest in oncology, where it potentiates chemotherapy while reducing side effects. User searches often focus on "melatonin dosage for anxiety" or "melatonin cancer prevention", reflecting public demand for evidence-based insights. However, variability in individual metabolism necessitates personalized dosing, a topic frequently addressed in telehealth consultations.
Melatonin (73-31-4): Safety Profile and Drug Interactions
While melatonin (73-31-4) is generally regarded as safe (GRAS), its interactions with anticoagulants, antidepressants, and immunosuppressants warrant caution. Common side effects include dizziness and daytime drowsiness, particularly with prolonged use. Internet users frequently search for "melatonin overdose symptoms" or "melatonin and blood pressure medications", emphasizing the need for clear guidelines. Recent meta-analyses confirm its safety in pediatric populations, though long-term effects remain under study. Regulatory agencies like the FDA classify it as a dietary supplement, but quality control varies across brands, prompting discussions about third-party testing and standardization.
Melatonin (73-31-4): Future Research and Innovative Formulations
Emerging research on melatonin (73-31-4) explores nanocarrier delivery systems to enhance bioavailability and target-specific action. Topics like "melatonin for gut health" and "melatonin in skincare" are gaining traction, driven by its role in mitochondrial function and collagen synthesis. Patent filings reveal advances in sublingual tablets and transdermal patches, addressing limitations of oral absorption. The compound's potential in mitigating neurodegenerative diseases (e.g., Alzheimer's) is a hot topic, with NIH-funded studies investigating its impact on amyloid-beta aggregation. As consumer interest shifts toward personalized nutraceuticals, melatonin's multifunctionality positions it as a cornerstone of integrative medicine.
73-31-4 (Melatonin) Related Products
- 2208-41-5(6-Hydroxy Melatonin)
- 8041-44-9(Melatonine)
- 1210-83-9(N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]acetamide)
- 39998-64-6(4-Hydroxymelatonin)
- 111-41-1(N-(2-Hydroxyethyl)ethylenediamine)
- 591-31-1(3-Methoxybenzaldehyde)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)